Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$881M |
| 2 |
DoorDash
DASH
|
+$403M |
| 3 |
Amgen
AMGN
|
+$403M |
| 4 |
Amazon
AMZN
|
+$282M |
| 5 |
Applied Materials
AMAT
|
+$231M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$592M |
| 2 |
Workday
WDAY
|
+$580M |
| 3 |
United Parcel Service
UPS
|
+$468M |
| 4 |
Apple
AAPL
|
+$438M |
| 5 |
Atlassian
TEAM
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.97% |
| 2 | Healthcare | 19.05% |
| 3 | Consumer Discretionary | 10.13% |
| 4 | Financials | 9.7% |
| 5 | Industrials | 9.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
Myriad Genetics
MYGN
$270M
| $849K | ﹤0.01% |
39,877
+1
| +0% | +$21 |
|
1727
Ingles Markets
IMKTA
$1.71B
| $847K | ﹤0.01% |
11,055
-4,680
| -30% | -$374K |
|
1728
Agilon Health
AGL
$1.53B
| $846K | ﹤0.01% |
5,552
+19
| +0.3% | +$3.16K |
|
1729
Navient
NAVI
$789M
| $845K | ﹤0.01% |
48,615
-4
| -0% | -$67 |
|
1730
Ingevity
NGVT
$2.54B
| $845K | ﹤0.01% |
17,709
| – | – |
|
1731
Calix
CALX
$2.26B
| $843K | ﹤0.01% |
25,431
| – | – |
|
|
XHR
1732
Xenia Hotels & Resorts
XHR
$1.9B
| $841K | ﹤0.01% |
56,038
+5
| +0% | +$70 |
|
|
NAPA
1733
DELISTED
The Duckhorn Portfolio, Inc.
NAPA
| $841K | ﹤0.01% |
90,308
+73,335
| +432% | +$672K |
|
1734
Teva Pharmaceuticals
TEVA
$40.8B
| $840K | ﹤0.01% |
59,563
| – | – |
|
1735
Talos Energy
TALO
$2.53B
| $840K | ﹤0.01% |
60,288
+147
| +0.2% | +$1.92K |
|
1736
HNI Corp
HNI
$3.24B
| $839K | ﹤0.01% |
18,612
| – | – |
|
1737
HighPeak Energy
HPK
$903M
| $839K | ﹤0.01% |
53,224
-18,405
| -26% | -$273K |
|
1738
Upbound Group
UPBD
$1.13B
| $838K | ﹤0.01% |
23,804
+2
| +0% | +$67 |
|
1739
Gentherm
THRM
$1.24B
| $837K | ﹤0.01% |
14,558
+1
| +0% | +$52 |
|
1740
Cinemark Holdings
CNK
$4.24B
| $833K | ﹤0.01% |
46,374
+2
| +0% | +$32 |
|
1741
Toyota
TM
$224B
| $832K | ﹤0.01% |
3,306
+465
| +16% | +$103K |
|
1742
Phinia Inc
PHIN
$2.72B
| $832K | ﹤0.01% |
21,641
-13,509
| -38% | -$440K |
|
|
VSTO
1743
DELISTED
Vista Outdoor Inc.
VSTO
| $829K | ﹤0.01% |
25,312
-15
| -0.1% | -$455 |
|
|
EVBG
1744
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $829K | ﹤0.01% |
23,802
+4
| +0% | +$113 |
|
1745
JELD-WEN Holding
JELD
$122M
| $829K | ﹤0.01% |
39,009
+2
| +0% | +$37 |
|
|
KE
1746
Kimball Electronics
KE
$595M
| $828K | ﹤0.01% |
38,235
+2,650
| +7% | +$59.9K |
|
|
ROIC
1747
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $826K | ﹤0.01% |
64,490
+3
| +0% | +$40 |
|
1748
NCR Voyix
VYX
$1.14B
| $824K | ﹤0.01% |
65,240
-1,484,329
| -96% | -$21.4M |
|
1749
Greif
GEF
$4.92B
| $824K | ﹤0.01% |
11,932
| – | – |
|
1750
Immunovant
IMVT
$7.93B
| $823K | ﹤0.01% |
25,520
+15
| +0.1% | +$547 |
|
Similar funds
Janus Henderson Group's Q1 2024 Portfolio in Review
As of Q1 2024, Janus Henderson Group held 2,613 positions worth $183B, up 9.3% from $168B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Janus Henderson Group's Q1 2024 filing shows 67 new, 1,353 increased, 903 reduced and 85 closed positions. Its largest new stake was CG Oncology: 1,521,432 shares worth $66.8M. The largest sale was Abbott, an estimated $592M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 33% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q1 2024 buy was CG Oncology: 1,521,432 shares worth $66.8M.
- Janus Henderson Group added most to Oracle in Q1 2024, an estimated $881M increase.
- Janus Henderson Group's biggest Q1 2024 reduction was Abbott, cutting an estimated $592M.
- Janus Henderson Group fully exited Immunogen Inc in Q1 2024, selling an estimated $327M.
- Janus Henderson Group's ten largest holdings make up 28% of its $183B portfolio in Q1 2024.
- Janus Henderson Group opened 67 new positions and closed 85 in Q1 2024.
- Janus Henderson Group's portfolio value rose 9.3% quarter-over-quarter to $183B.
Based on Janus Henderson Group's 13F filing for Q1 2024, filed 15 May 2024.